Skip to content

Standards & Guidelines

These Standards and Guidelines are presented from the perspective of the AABH national provider network. Key definitions related to partial hospitalization and intensive outpatient programming will be presented. Important information about regulatory coordination and program structure will also be provided.

This document has been designed to enable programs to:

  • achieve effectiveness and best practices in service delivery,
  • maintain regulatory compliance,
  • and provide safety through clinical guidelines, standards, and best practices.

Partial hospitalization programs (PHP) and intensive outpatient programs (IOP) may differ from one region to another due to multiple factors such as specialized workforce availability, culture, resources, or health insurance coverage inconsistencies. These standards and guidelines focus on best practice for care in PHP and IOP settings; however, AABH acknowledges that some contracts with payers may override the standards in this document. It is therefore necessary for providers of PHP and IOP services to familiarize themselves with all current applicable requirements and interpretations for their local environment.

PHPs and IOPs are designed to help individuals understand their illness, reduce the impact of functionally debilitating symptoms, and cope with challenging situational crises. People need to feel hope, find purpose, and care for others. Whenever possible, they want to keep their job and maintain their homes. The treatment mission of PHP and IOP services is to develop a setting that provides the tools for recovery. The latest medication advances, therapeutic techniques, and peer connections meet individuals “where they are” in a positive milieu that fosters support and change.

PHPs and IOPs should represent the core of psychosocial treatments. The final rules pertaining to the implementation of the parity legislation were presented in November of 2013. At the time, Pamela Hyde, JD, SAMHSA Director, announced that partial hospitalization and intensive outpatient treatment were specifically included as essential “intermediate behavioral healthcare” treatment options.1 This landmark decision validates over 40 years of effort by behavioral health professionals throughout the country to provide intensive ambulatory treatment and avert or reduce hospitalizations while creating an environment of personal recovery for countless Americans.

The identification of target populations with criteria for admission to, continuation of, and exclusion from each level of care will be delineated. Specific aspects of program design will be discussed as they apply to specialized practice settings. A description of the essential treatment services such as group, occupational, and psycho-educational therapies will be provided. As providers have found it helpful to provide specialized programming for sub-populations dealing with similar behavioral health challenges, these guidelines outline unique factors related to some of those specialty populations, including:

  • Child & Adolescents;
  • Chemical Dependency;
  • Co-occurring Disorders;
  • Older Adults;
  • Eating Disorders;
  • And Perinatal Women.

Necessary elements for documenting services provided include a discussion about electronic medical records. Linkages related to successful treatment will be considered. With recent changes to regulatory requirements in onsite visits, this document provides guidance in preparation for regulatory reviews. Outcomes have become increasingly more important not only internally, but to external agencies, including regulatory agencies, insurance providers and consumers. Both performance and clinical measurement will be addressed.

Specialty Populations with Additional Standards

Organizations may choose to provide a PHP or IOP for a specifically defined population. This section contains specific considerations when developing a program for a population identified in the list. While this section is not inclusive of all specific populations, these represent the populations in which there are a significant number of programs, enough to be establishing best practice. As other programs specific to a population grow to needing a national standard, they will be added to this section.

For clinical outcome measures related to the populations below, AABH has a table of clinical outcome measures that are currently used in PHPs and IOPs. This table is available to members HERE.

Definition/Target Population

By providing an intensive level of care that spans the gap between traditional inpatient and outpatient levels of care, Child and Adolescent Partial Programs are an important part of the continuum of behavioral healthcare. These programs often allow children and adolescents to avoid inpatient hospitalization, decrease lengths of stay otherwise required in inpatient or residential settings, or to support the child/adolescent with any transitions such as foster care when needed. Typically, individuals 18 years of age and younger are served. However, this range may extend to 21 years of age dependent upon the individual’s developmental level and the goals and objectives and licensing requirements of any program. Child and adolescent programs provide an intensive therapeutic milieu that is designed to serve the child and/or adolescent (and their family) within the least restrictive therapeutically appropriate context. These programs are both community- and hospital-based and may be structured with after school or full day services. The overall expected outcome is the achievement of symptom and functional improvement on the part of the child/adolescent and the family.

Specific Considerations

  • They may be part of educational or residential facilities. However, they should be a separate, identifiable unit and represent a continuum of therapeutic modalities  that are evidence based for children and adolescents.
  • The individual’s family and/or legal caretakers must be involved.
  • When developing program schedule, consider your population and how you will structure school (i.e. teacher on staff vs. Monitored study time vs. Programming after school hours).  State laws may apply. Some regulators have requirements about education components in these programs.
  • Staff members must be trained and experienced in child and adolescent behavioral health, family therapy, milieu therapy, and therapeutic crisis intervention.
  • Treatment modalities and techniques must be developmentally appropriate, and evidence-based for children and adolescents.
  • The assessment and treatment plan should address improvement of social skills and functioning via the therapeutic milieu.    
  • Treatment should include collaboration with school, involved community agencies and established providers.

Performance and Outcomes

  • Establishment of a safety plan that allows for the child/adolescent to maintain safety in a community setting.
  • Improvement in symptoms and functioning to allow the child/adolescent to return to a school setting.
  • Improvement in symptoms and functioning as evidenced by outcomes measurement tools that are evidence based for children and adolescents.
  • Improvement in functioning and communication within the family system and/or home environment.

Definition/Target Population

Older Adult programs are an important means of delivering behavioral health treatment to adults age 55 and older. The achievement of clinical stability and a reduction in symptomatology must be considered in the context of realistic and achievable goals especially given the complex medical and psychosocial stressors that often impact the older adult population. A higher level of monitoring of overall behavioral health and physical functioning is important.  The value of these programs in clarifying diagnoses, assessing function, and determining one’s capacity for independence or personal safety cannot be underestimated. Programs can provide daily symptom management, while at the same time, necessary case management services are engaged to foster the highest level of functioning possible. Intensive outpatient services have been developed to meet specific clinical needs when the individual is not determined to require the intensive daily services of partial hospitalization or is unable physically to meet the attendance requirements of such programs or when less frequent monitoring in inappropriate.

Specific Considerations

  • The presence of comorbid physical illness must be addressed and often makes the frequency and duration of attendance more challenging.
  • The presence of substance abuse has often been underreported due to cultural or generational biases. Therefore, it is important to collect a thorough substance abuse history.
  • A recovery model that focuses on increased quality of life is essential to give the older adult investment and purpose in treatment.
  • Fatigue, sensory impairment, decreased concentration ability, and discomfort with transitions or changes in programmatic structure are challenging factors to address in program development.
  • Many seniors live in isolation, so timely and appropriate aftercare is needed to ensure that gains made in the program remain.
  • Cognitive and physical impairments may make day-long treatment services demanding for some individuals.
  • Modifying the treatment techniques may be necessary in terms of presenting information more slowly and concretely and with a narrower focus than may be necessary with young and middle adults.
  • Groups that are structured to be repetitive, slower, and engage patients at multiple sensory levels are very important and can reduce the impact of physical and cognitive limitations on treatment.
  • It is also important to address issues specifically faced by older adults such as grief and loss, changes in professional and personal roles, limitations of social support, impact of physical limitations on wellbeing, stigma related to aging, and death and dying.

Performance and Outcomes

  • Performance Improvement for older adult programs is essential and should be determined by the mission and specific needs of those who are being served. The processes and results of access, engagement, treatment, and discharge should be considered.
  • A focus on medication adherence, therapeutic impact, and relationship between psychiatric and physical medications should also be considered.

Definition/Target Population

Programs serving pregnant women or new mothers typically care for women with some type of Perinatal Mood and Anxiety Disorders (PMAD). The disorders are also commonly called Postpartum depression, perinatal mood disorders, or PMD. These disorders are characterized by significant changes to mood during pregnancy and up to 3 years postpartum. Examples of symptoms include high anxiety, sadness, depression, mood swings, elevated mood, irritability, intrusive thoughts, and more.

Between 10-25% of women experience some form of PMAD during pregnancy or after the birth of a child. If left untreated, there is significant impact on women and their families.10 This includes depression, psychosis, bipolar disorder, anxiety, panic, obsessive compulsive disorders, and post-traumatic stress disorders. Suicide is the leading cause of death in the postpartum time period.11

Specific Considerations

  • Postpartum Psychosis is a true psychiatric emergency. Mothers should never be left alone with a baby if they are diagnosed with postpartum psychosis. Women with postpartum psychosis will need referral into acute inpatient psychiatric treatment.
  • Availability of a nursery is critical for new moms. If possible, consider a nursery onsite. Women in the program should have the option to bring babies to group or leave in nursery. Programs should consider the focus of some of their programming on maternal fetal attachment with bonding groups like infant massage, playing with baby, etc.)12
  • Important to have prescribers with expertise in prescribing during pregnancy and lactation.

Treatment aims to minimize fetal/neonatal exposure to both maternal mental illness and medication

  • Clinicians in the program should be well versed in perinatal mood and anxiety disorders.
  • It is important for programs to provide lactation consultation in the program as working through difficulties with breastfeeding is a common treatment goal with this population.
  • Co-morbid substance use is common so drug screens should be administered upon admission and use assessed throughout the stay. In a perinatal program it is important to understand that the baby in utero also needs consideration from the program and moms that breastfeed who are using substances are also putting their babies at risk.  These are important things to address during the course of treatment in these programs. 
  • Family work is crucial and should be a part of every client’s treatment plan. Dads can also struggle with paternal depression and the mental health of the whole family is key to successful outcomes.  Programs should consider brief family therapy and referrals for family members that need additional treatment.  Resources from Post-Partum Support Internation may be helpful in finding additional support for spouses.
  • Group therapy is an important part of treatment as research indicates that group therapy for women with postpartum depression led to a reduction in depression scores (Byrnes, 2018).
  • Programs should also incorporate interpersonal therapy and cognitive behavioral therapy as these have been effective in treatment of perinatal depression (Van Neil and Payne, 2020). A solid aftercare plan is crucial for success with this population. Often primary care physicians, OBGYN’s and Pediatricians need additional help and consultation from a trained psychiatric provider if they are going to be a part of the aftercare plan for clients, especially if they are managing medications. Consideration of teletherapy options is up and coming because of childcare needs and difficulties moms have leaving the home to get to appointments. 

Performance and Outcomes

Programs should create a plan that includes performance measures for the program as well as appropriate clinical outcome measures specific to postnatal issues and clinical issues specific to any additional diagnoses for admitted participants.

Definition/Target Population

The Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) has refined the diagnostic categories of eating disorders, defining them as Anorexia Nervosa, Bulimia Nervosa, Binge Eating Disorder, Avoidant/Restrictive Food Intake Disorder (ARFID) and eating disorder not otherwise specified, which include a wide range of subclinical symptoms. See DSM-5 for details on these diagnostic categories, and the levels of severity. Persons meeting “Severe and Extreme” level of severity should be treated within a Partial Hospital Psychiatric level of care setting, as long as the patient is medically stable. If medically unstable, inpatient hospitalization is necessary, stepping down to a PHP level of care.

A growing body of evidence suggests that partial hospitalization outcomes are highly correlated with treatment intensity and that more successful programs involve patients at least 5 days/week for 8 hours/day

Clients with eating disorders may enter PHP level of care with a body mass index (BMI) which measures the relationship between height and weight, of 17.5 (adults) or less with a diagnosis of anorexia nervosa or may be of normal weight with a bulimia nervosa diagnosis, while they may be obese with a BMI of 30 or more or morbidly obese with a BMI or 40 or more.  Menses have usually ceased if body mass is extremely low or high.

Specific Considerations

  • Patients are assessed to be medically stable with labs to include but not limited to:
    • complete blood count
    • comprehensive serum metabolic profile, including phosphorus and magnesium
    • thyroid function test
    • Electrocardiogram (ECG), if clinically indicated
    • Body Mass Index (BMI)
    • Heart Rate
    • Screening for eating disorder behaviors
    • Any additional laboratory testing, as determined by the organization and in accordance with the level of care provided.
  • According to the American Psychiatric Association’s Eating Disorder Guideline 2006, clients who are appropriate for partial hospitalization need daily supervision and structure from meal to meal to gain or prevent purgative and binge eating behaviors. The structure is needed to monitor before, during and after eating meals and snacks.
  • For those with AN, weight restoration may need daily monitoring to prevent re-feeding syndrome.
  • Movement needs to be monitored hourly, determining how much movement or exercise is medically safe for each client’s stability. Medical oversight is necessary with additional daily, hourly structure to contain and monitor client movement.
  • Medical personnel address ongoing medical and physical health issues and assess and manage medication therapies.
  • Dietitians work with patients and their families to move in the direction of nutritional rehabilitation and weight restoration.
  • Eating disorder partial programs provide staff- supervised meal and snack groups, regular monitoring of weight and vital signs, and a variety of groups aimed at addressing symptom management and augmenting patients coping skills and strategies (as they relate to both the eating disorder and other behavioral health co-morbidities).
  • Initial discharge criteria are formulated upon admission and are based on objective data such as achievement of a certain percentage of ideal body weight or targeted weight gain, or weight loss (if binge eating) as well as ability to function with less structure daily.

Performance and Outcomes

Programs should create a plan that includes performance measures for the program as well as appropriate clinical outcome measures specific to eating disorders and clinical issues specific to any additional diagnoses for admitted participants.

Definition/Target Population

Chemical dependency partial hospitalization programs and intensive outpatient programs serve populations who present primarily with substance use disorders that have relatively minimal or no mental health disorders impacting current functioning. Programs for chemically dependent individuals are designed to serve those within a less restrictive environment (for example, less restrictive than inpatient or residential) which allows the individual to practice new recovery and coping skills within his/her natural environment and to assess the individual strengths and weaknesses associated with those recovery and coping skills. The program can also function as a first step to achieve a measure of sobriety, and to assist in determining a differential diagnosis once the individual has begun the recovery process.

 

Services are offered to individuals whose medical condition, including the possibility of severe withdrawal, is not as dangerous or severe as to warrant 24-hour inpatient or residential monitoring. As previously mentioned, individuals who have diagnoses for both mental health and substance use disorders of which only one is currently active, may be treated in a co-occurring (“dual diagnosis”) treatment setting, or in either an addictions or psychiatric treatment setting (depending upon which problem is currently active). Individuals in treatment include both those who participate voluntarily, as well as those mandated by the legal system.  Services may include group, individual, couples, family therapy and medication management for symptom management.  Evaluation for medication –assisted treatment (MAT) services may also be indicated.

Specific Considerations

  • Treatment is best conceptualized as a phased continuum of care that progresses from management of active symptoms and problems to establishing recovery/relapse prevention plans.
  • Coordination and involvement with family members and significant others is an important part of treatment whenever possible.
  • All chemical dependency PHP and IOP programs must have clearly delineated procedures for addressing client’s detoxification, withdrawal, and other medical needs. Additionally, any exclusionary citeria must be clearly defined.
  • Confidentiality guidelines pertaining to individuals in chemical dependency treatment tend to be more restrictive than for those individuals in mental health treatment.
  • Utilizing a Motivational Interviewing approach to assessment (as well as ongoing treatment) with individuals with chemical dependency is considered to be a best practice.
  • Some programs choose to identify guidelines for early administrative discharge based on pre-determined number of relapses and other forms of treatment-interfering behaviors.

Performance and Outcomes

  • The American Society of Addiction Medicine’s (ASAM) Patient Placement Criteria (ASAM PPC-2R) (previously mentioned) is considered a best practice for assessing and determining level of care placement for individuals with substance use disorders.6

This comprehensive approach focuses on the following areas, or dimensions:

    1. Psychoactive substance history & detoxification status
    2. Physical health
    3. Emotional/behavioral/cognitive functioning
    4. Readiness for change
    5. Relapse potential
    6. Recovery environment
  • A certain measure of relapse is to be expected and treatment remains appropriate to client needs after clinical review.
  • Programs  will use their identified outcome measure tool  to track clients progress in the program.

Definition/Target Population 

Co-occurring behavioral illness (dual diagnosis) is defined as conditions experienced by individuals with concurrent DSM mental health and substance use disorder diagnoses. According to SAMHSA, “While these disorders may interact differently in any one person (e.g., an episode of depression may trigger a relapse into alcohol abuse, or cocaine use may exacerbate schizophrenic symptoms), at least one disorder of each type can be diagnosed independently of the other.”7 

Specific Considerations 

  • Co-occurring treatment providers must be well versed in the diagnosis and treatment of concurrent mental health and substance use disorders. “Staff in settings providing integrated substance abuse and psychiatric treatment should be fully oriented in each other’s disciplines. Individuals with co-occurring disorders should be able to receive services from primary providers and case managers who are cross-trained and able to provide integrated treatment themselves.”7 
  • Traditionally, substance abuse and mental health facilities are treated as separate programs and are often licensed and reviewed separately in many states. Facilities that provide treatment for both behavioral health conditions are not formally designated as a single treatment program in most areas. While there is significant financial and clinical impetus to provide these services in an integrated manner, state licensing dictates the extent to which programs may be integrated. 
  • Individuals with co-occurring disorders tend to relapse frequently, placing them at greater jeopardy of a marginalized social existence. 
  • The inclusion of motivational interviewing techniques has been an important addition to clinical programming and has led to increased engagement of individuals who display avoidance or ambivalence toward treatment.8 
  • In many program settings, the inclusion of individuals in different phases of recovery can be used to good clinical advantage. 
  • To ensure effectiveness of co-occurring programs, it is important to not rely only on patient report but to utilize data from various sources to ensure ongoing recovery. 
  • All co-occurring programs must have clearly delineated procedures and linkages for addressing client’s detoxification, withdrawal, and other medical needs. 
  • Treatment planning for the individuals with co-occurring disorders incorporates knowledge of both the mental health and substance use components of the illness. 
  • Utilizing a Motivational Interviewing approach to assessment (as well as ongoing treatment) with individuals with chemical dependency is considered to be a best practice.8 
  • The Co-Occurring Disorders: Integrated Dual Diagnosis Treatment Implementation Resource Kit provides the following four key principles for gathering information about mental health and addiction disorders: 
    1. Because many clients with severe mental illness have substance use disorders and vice versa, it is important to ask all clients about substances and mental health issues. 
    2. Gather information from other sources (family, hospital records, and urine screens) in addition to the client. Some clients are reluctant to talk about behaviors that they believe others disapprove of, such as drug use or illegal activities.  
    3. If information gathered from sources does not agree with what the client tells you, ask the client to help resolve the discrepancy. 
    4. Because assessments completed soon after meeting a client or in the context of intoxication, withdrawal, or severe psychiatric symptoms are inaccurate, it is important to continue to gather information over time.9 
  • Some programs choose to identify guidelines for discharge based on a pre-determined number of relapses and/or other forms of treatment-interfering behaviors. 
  • Programs are encouraged to be ready for medical emergencies related to substance abuse such as narcotic withdrawal crises 9 some programs keep medications onsite for emergency use and have staff competent in admistration. 

Performance and Outcomes  

  • The American Society of Addiction Medicine’s (ASAM) Patient Placement Criteria (ASAM PPC-2R) (previously mentioned) is considered a best practice for assessing and determining level of care placement for individuals with substance use disorders.6  

This comprehensive approach focuses on the following areas, or dimensions: 

    1. Psychoactive substance history & detoxification status  
    2. Physical health 
    3. Emotional/behavioral/cognitive functioning 
    4. Readiness for change 
    5. Relapse potential 
    6. Recovery environment 
  • Relevant factors such as relapse and recidivism, attendance at self-help meetings, level of sobriety, post-discharge adjustment (including improvement in housing status, use of recovery-oriented peer or social support, and vocational training/placement), and legal issues pre- and post-treatment may be measured. 

The downloadable version of the Standards and Guidelines reflects the most recent publication and may not accurately reflect the online version. The downloadable version is created every three years from the information contained in the online version of the Standards and Guidelines. To download the latest e-edition click here: 2021 Edition – Standards and Guidelines.